User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.

  1. Gibson K. L., Gipson D. S., Massengill S. A., Dooley M. A., Primack W. A., Ferris M. A., Hogan S. L., Predictors of Relapse and End Stage Kidney Disease in Proliferative Lupus Nephritis: Focus on Children, Adolescents, and Young Adults, 10.2215/cjn.00490109
  2. Perfumo F, Martini A, Lupus nephritis in children, 10.1191/0961203305lu2065oa
  3. Barron Karyl S., Silverman Earl D., Gonzales Juanita, Reveille John D., Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus, 10.1002/art.1780360310
  4. Mina Rina, Brunner Hermine I., Pediatric Lupus—Are There Differences in Presentation, Genetics, Response to Therapy, and Damage Accrual Compared with Adult Lupus?, 10.1016/j.rdc.2009.12.012
  5. Sandborg Christy I., Childhood systemic lupus erythematosus and neonatal lupus syndrome : , 10.1097/00002281-199809000-00014
  6. Wang CH, Yao TC, Huang YL, Ou LS, Yeh KW, Huang JL, Acute pancreatitis in pediatric and adult-onset systemic lupus erythematosus: A comparison and review of the literature, 10.1177/0961203310387179
  7. Appel G. B., Contreras G., Dooley M. A., Ginzler E. M., Isenberg D., Jayne D., Li L.-S., Mysler E., Sanchez-Guerrero J., Solomons N., Wofsy D., , Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis, 10.1681/asn.2008101028
  8. Dooley Mary Anne, Jayne David, Ginzler Ellen M., Isenberg David, Olsen Nancy J., Wofsy David, Eitner Frank, Appel Gerald B., Contreras Gabriel, Lisk Laura, Solomons Neil, Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis, 10.1056/nejmoa1014460
  9. Sinclair A., Appel G., Dooley M.A., Ginzler E., Isenberg D., Jayne D., Wofsy D., Solomons N., Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS), 10.1177/0961203307084712
  10. Austin Howard A., Klippel John H., Balow James E., Le Riche Nicole G.H., Steinberg Alfred D., Plotz Paul H., Decker John L., Therapy of Lupus Nephritis, 10.1056/nejm198603063141004
  11. Fu YF, Clin Nephrol, 55, 318 (2001)
  12. Dooley MA, J Am Soc Nephrol, 10, 833 (1999)
  13. Gaubitz Markus, Schorat Annette, Schottel Heiko, Kern Peter, Domschke Wolfram, Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial, 10.1191/096120399678840927
  14. Baskin Esra, Ozen Seza, Çakar Nilgun, Bayrakci Umut S., Demirkaya Erkan, Bakkaloglu Aysin, The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis, 10.1007/s00467-009-1291-x
  15. Buratti S, J Rheumatol, 28, 2103 (2001)
  16. Dittrich K., Ross S., Benz K., Amann K., Dötsch J., Experience with Mycophenolate Mofetil as Maintenance Therapy in five Pediatric Patients with Severe Systemic Lupus Erythematosus, 10.1055/s-0029-1234130
  17. Falcini F, Capannini S, Martini G, La Torre F, Vitale A, Mangiantini F, Nacci F, Cerinic MM, Cimaz R, Zulian F, Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study, 10.1177/0961203308094999
  18. Fujinaga Shuichiro, Ohtomo Yoshiyuki, Hara Satoshi, Umino Daisuke, Someya Tomonosuke, Shimizu Toshiaki, Kaneko Kazunari, Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen, 10.1007/s00467-008-0800-7
  19. Gargah Tahar, Goucha-Louzir Rim, Lakhoua Mohamed Rachid, Place du mycophénolate mofétil dans la néphropathie lupique proliférative de l’enfant, 10.1016/j.nephro.2010.07.001
  20. Kazyra I., Pilkington C., Marks S. D., Tullus K., Mycophenolate mofetil treatment in children and adolescents with lupus, 10.1136/adc.2009.178608
  21. Lau Keith K., Ault Bettina H., Jones Deborah P., Butani Lavjay, Induction Therapy for Pediatric Focal Proliferative Lupus Nephritis: Cyclophosphamide Versus Mycophenolate Mofetil, 10.1016/j.pedhc.2007.07.006
  22. Isenberg David, Appel Gerald B., Contreras Gabriel, Dooley Mary A., Ginzler Ellen M., Jayne David, Sánchez-Guerrero Jorge, Wofsy David, Yu Xueqing, Solomons Neil, Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study, 10.1093/rheumatology/kep346
Bibliographic reference Sundel, R ; Solomons, N ; Lisk, L ; Houssiau, Frédéric. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.. In: Lupus, Vol. 21, no. 13, p. 1433-43 (2012)
Permanent URL http://hdl.handle.net/2078.1/122995